PD0325901 - Mirdametinib

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1408

CAS [391210-10-9]

MF C16H14F3IN2O4
MW 482.19

  • Purity: 99%
  • Optical purity: >98% e.e.
  • Soluble in DMSO

PD0325901

Description

Potent, highly specific non-ATP-competitive inhibitor of MEK (aka MKK) 1/2; a derivative of PD184352 (Axon 1368) to improve bioavailability; clinical candidate and highly recommended tool to inhibit MKK1 or MKK1 plus MKK5 in cells.
* PD0325901 and CHIR99021 (Axon 1386) from Axon Medchem are often used together as perfect 2i in stem cell research (Axon 2128).

*Promotion: PD 0325901 is also part of Inhibitor Set(s):

Axon 2128 Axon 5009 Axon 5010 Axon 5011

 

Prime Source Information:
PD0325901 from Axon Medchem has been procured by many labs as drug standard for generating reliable and reproducible biological data, evidenced by many recent publications.

KEYWORDS: PD0325901 | supplier | MEK1 inhibitor | Mirdametinib | PD-0325901 | PD 0325901 | PD325901 | PD-325901 | PD 325901 | CAS [391210-10-9] | MAPK | MEK1 | MEK2 | Inhibitor | MKK | MKK1 | stem cell | pluripotent | renewel | DNA | lesion

Order
Size Unit Price Stock
2 mg €50.00 In Stock
5 mg €70.00 In Stock
25 mg €220.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €120.00 In Stock
2 x 25 mg €360.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...